To determine the effect of interferon (IFN) on the pathogenesis of pseudorabies virus (PRV), porcine nasal mucosal explants were first treated with recombinant porcine methionyl-IFN-atl and then infected with one of three strains of PRV. The stroma of treated mucosal explants were protected against infection with virulent PRV or PRV of intermediate virulence because the infection was restricted to the epithelial cells. In contrast, untreated mucosal explants were readily infected by virulent PRV or PRV of intermediate virulence; the infection spread from epithelial cells to stromal fibroblasts. Avirulent PRV infection was restricted to the epithelial cells of treated and untreated mucosal explants. IFN treatment limited the extent of all three PRV infections in the epithelial cells. Cultured porcine fibroblasts and porcine kidney cells were also treated with IFN and subsequently infected with PRV; infection was prevented in most porcine fibroblasts and the virus yield from porcine kidney cells was reduced. Budding of virulent PRV nucleocapsids through the inner nuclear membrane was observed more frequently in treated than in untreated mucosal explants and enveloped virus particles accumulated between the inner and outer nuclear membranes, indicating that the membrane-associated events of PRV replication had been affected. We conclude that IFN-at protects stromal fibroblasts against PRV infection and reduces virus replication in epithelial cells.
Introduction
The interferons (IFNs) form a major defence system against several virus diseases affecting mammals (Gresser et al., 1976; Stewart et al., 1969) , e.g. the resistance of mice to herpes simplex virus depends on the endogenous production of IFN by macrophages (Kirchner et al., 1983) . Viral and synthetic substances have been used to induce IFN in pigs (Vengris & Mar6, 1972a; La Bonnardi6re &Laude, 1981; Loewen & Derbyshire, 1986) and porcine cell cultures (Amadori et al., 1987; Vengris & Mar6, 1972 b; La Bonnardi6re et al., 1984) , and IFN can also be induced in pigs by intravenous inoculation with pseudorabies virus (PRV) (Vengris & Mar6, 1972a) . Lomniczi (1974) induced IFN production with avirulent PRV in chicken embryo fibroblasts but not in porcine kidney cells. The effect of porcine IFN on epithelial cell cultures infected with PRV is weak compared to its strong effect on RNA viruses, such as foot-and-mouth disease virus and vesicular stomatitis virus (Amadori et al., 1987; Vengris & Mar6, 1972b; Lomniczi, 1974) . A study of the comparative pathogenesis of three PRV strains in pigs revealed marked differences in the infection in nasal 0000-9984 © 1991 SGM mucosa and suggested that IFN was one of the possible causes of these differences (Pol et al., 1989) .
Leukocytes produce IFN-~ whereas epithelial cells and fibroblasts produce IFN-fl after virus infection or contact with dsRNA. To study the effects of IFN-~ on PRV infections of both epithelial cells and fibroblasts, we treated nasal mucosal explants with recombinant porcine methionyl-IFN-~l (PolFN-~I) and infected them with one of three PRV strains of different virulence. The results suggest that PolFN-~I protected fibroblasts but not epithelial cells against virulent PRV infection.
Methods

IFN.
PolFN-ctl produced in Escherichia coli was provided by Dr C. La Bonnardi6re, (INRA, Thiverval Grignon, France) . The antiviral activity of the stock solution was l0 s units (U) per ml as assayed on Madin-Darby bovine kidney (MDBK) cells (Lefevre & La Bonnardi6re, 1986; La Bonnardi6re & Laude, 1981) .
Virus strains. The virulent PRV strain, Northern Ireland 3 (NIA-3), was kindly provided by Dr J. B. McFerran (Belfast, U.K.).
The mildly virulent PRV strain, 2.4N3A, a deletion mutant virus, was used. This virus was derived from strain NIA-3 by deleting 2.4 kbp in the unique short (Us) region of the genome. PRV strain 2.4N3A does not express glycoprotein gI and lacks an 11K protein, probably a phosphoprotein of the tegument (Frame et al., 1986) . The construction and characterization of PRV strain 2.4N3A have been described elsewhere Berns et al., 1985; Quint et al., 1987) .
Avirulent PRV strain Bartha was purchased as a commercial vaccine (Duphar B. V.). The PRV strain Bartha genome has a 3.8 kb deletion in the same part of the Us region as PRV strain 2.4N3A, it does not express gI and gp63 (Mettenleiter et al., 1985; Petrovskis et al., 1986) and it lacks the 11K and 28K proteins. In addition, glycoprotein glII is not efficiently glycosylated or matured (Robbins et al., 1989) ; PRV strain Bartha is also defective in a gene involved in nucleocapsid assembly (Lomniczi et al., 1987) .
All viruses contained the genetic information for thymidine kinase. The virus strains were passaged several times on secondary porcine kidney cells as described elsewhere (De Leeuw et al., 1982) and stocks were stored at -70 °C. Before use, the virus suspensions were diluted with Eagle's MEM (EMEM) to a concentration of 107 p.f.u./ml.
Pigs. Nasal mucosa was obtained from Dutch Landrace pigs of the specific pathogen-free herd of the Central Veterinary Institute, Lelystad, The Netherlands. Pigs were free of antibodies against PRV and were between 5 and 7 weeks old.
Cell cultures
(i) Nasal mucosal explants. Pigs were killed and exsanguinated, and the nose was removed and split through the nasal septum. Rectangular (10 x 5 mm) pieces of nasal mucosa were collected and placed in sterile, dry, plastic macroplates, containing six wells of 35 mm (Costar), with the epithelium facing upwards, and covered with EMEM supplemented with 10% foetal calf serum (FCS) and antibiotics.
(ii) Porcine kidney cells. Secondary porcine kidney cells were cultured in plastic macroplates according to standard methods (De Leeuw et al., 1982) . PRV infections were performed in duplicate on 2-day-old confluent monolayers.
(iii) Porcine fibroblasts. Clumps of subcutaneous connective tissue from newborn germ-free piglets were cultured in EMEM supplemented with 10% FCS. After 5 days the clumps were removed and the fibroblasts were treated with trypsin and transferred to sterile macroplates with EMEM supplemented with 10% FCS. PRV infections were performed in duplicate on 2-day-old confluent monolayers.
Experimental procedure. Nasal mucosal explants, kidney cells and fibroblasts were incubated for 16 h at 37 °C in EMEM supplemented with 10% FCS and antibiotics, with or without 1000 U PolFN-ctl/well. The cell cultures were then washed twice with EMEM and infected with PRV. A virus suspension (1 ml containing 107 p.f.u.) was placed onto monolayers of cells in macroplate wells or on top of 2-5 cm 2 of mucosal explant (the m.o.i, for monolayers and explants was approximately 1 p.f.u./cell) and incubated at 37 °C for 1 h. The cultures were washed twice with EMEM and the nasal mucosal explants were transferred to sterile 35 mm macroplates. All cell cultures were grown further in EMEM supplemented with 10% FCS and antibiotics. Virus culture supernatants were collected 48 h after inoculation for virus titration. Monolayers and explants were fixed and processed for immunohistochemical study, morphometric study and transmission electron microscopy 24 and 48 h after virus inoculation.
Control mucosal explants and monolayers of kidney cells and fibroblasts were treated as described above, omitting the virus incubation.
Virus titration. Culture supernatants were collected 48 h after inoculation, frozen and stored at -70 °C until virus titres were determined in secondary porcine kidney cells as described by De Leeuw et al. (1982) .
Immunohistochemistry. Nasal mucosal explants were fixed in 10% neutral buffered formalin, dehydrated, embedded in paraffin wax ('Paramat" pastillated, 'Gurr'; BDH) and sections were cut and picked up on glass slides. After removal of the paraffin, the slides were placed in methanol containing 0.03 % H202 for 30 min to remove endogenous peroxidase activity. Sections were incubated with rabbit anti-PRV serum for 30 min. After being washed in phosphate-buffered saline (PBS), the slides were covered with sheep anti-rabbit peroxidase conjugate (Institut Pasteur, Paris, France) in PBS for 60 min and washed again in PBS. Peroxidase activity was visualized with 0.5 mg 3,Y-diaminobenzidine tetrahydrochloride (Sigma) per ml and 0.05 MTris-HCl pH 7.6 containing 0.01% H202. Control slides were treated as described above but the first incubation step with anti-PRV serum was omitted. Sections were counterstained with haematoxylin for 30 s, washed in tap water, dehydrated in graded alcohols, clarified in xylene and mounted in DPX (BDH).
Morphometric examination. Infected areas of nasal mucosa in immunohistochemically stained sections were measured with a crosshair cursor on a magnetic tablet (MOP Videoplan Kontron Image Analysis S~/stems) and a Leitz Orthoplan microscope. Infected areas were measured at a magnification of 250 x and expressed as a percentage of the total length of the mucosa in that section. Each value represents the mean ( + S.D,) of six experiments, with a total mucosal length of 600 mm.
Transmission electron microscopy. The nasal mucosal was fixed in a mixture of 0-8% glutaraldehyde and 0.8% osmium tetroxide in a veronal acetate buffer, washed extensively and then stained in 1-0% uranyl acetate (Hirsch & Fedorko, 1968) . Tissues were washed then dehydrated in alcohol and embedded in Epon resin. Ultrathin sections were stained with 0-2% lead citrate in 0.1 M-NaOH and uranyl acetate (Venable & Coggeshall, 1965) and examined in a Philips CM10 transmission electron microscope. The morphogenesis of each PRV strain was studied in at least 200 cells per virus strain. Results were obtained in a blind test.
Results
Morphometric examination
Treating nasal mucosal explants with PoIFN-0tl before inoculation with each of three PRV strains retarded the spread of viral infection in the epithelium for 24 h after inoculation (Fig. 1 ) and 48 h after inoculation Bartha virus and 2.4N3A virus had spread less in IFN-treated epithelium than in untreated epithelium. At this time NIA-3 virus had spread almost as much in IFN-treated epithelium as it had in untreated tissue (Fig. l) .
Spread of PR V infection
Large areas of the nasal epithelium were infected by the virulent NIA-3 and mildly virulent 2.4N3A virus 24 h after inoculation. After 48 h, these virus strains had invaded the lamina propria through the basal lamina (Fig. 2a, c) . Treatment with PoIFN-~I before inoculation restricted the infection of both NIA-3 virus and 2.4N3A virus to the epithelium. 48 h after inoculation, the stromal fibroblasts were almost protected from virus infection (Fig. 2b, d ), although in some places a few stromal cells were infected by NIA-3 virus ( Fig. 2b ; Table 1 ).
After infection with the avirulent Bartha virus, viral antigens were detected only in the epithelium, regardless of whether the cells had been treated with IFN ( Fig. 2e,  f ; Table 1 ). Porcine fibroblasts and porcine kidney cells were both readily infected by all three virus strains; treatment with PolFN-al before inoculation with PRV protected most fibroblasts against PRV infection but could not protect porcine kidney cells against PRV infection (Table 1) .
Virus replication
Less virus was produced in IFN-treated nasal mucosa than in untreated nasal mucosa (Table 2) . Treatment with PolFN-~I reduced the virus yield from porcine fibroblasts considerably but reduced the virus yield from porcine kidney cells only slightly (Table 2) .
Viral morphogenesis
In untreated nasal epithelial cells, 24 and 48 h after inoculation with NIA-3 virus, the virus was either present as nucleocapsids in the nucleus, lying close to the inner nuclear membrane (NM), or as enveloped virus particles in the cytoplasm. The actual envelopment of nucleocapsids by budding through the nuclear envelope was rarely observed (Fig. 3 a) .
After treatment of nasal mucosa with PolFN-ctl, nucleocapsids were observed in the perinuclear space between the inner and the outer NM (Fig. 3b) . Naked nucleocapsids were detected in the cytoplasm near membranes of the smooth endoplasmic reticulum (SER), some of which were in the process of being enveloped (Fig. 3b) .
The morphogenesis of NIA-3 virus in porcine kidney cells and fibroblasts was identical to that in nasal epithelium cells. IFN treatment reduced the number of intranuclear, cytoplasmic and extracellular virions and changed the predominant site of viral envelopment to the SER membranes (Table 3) .
In untreated cells, 2.4N3A virus was enveloped predominantly in the cytoplasm by budding through SER membranes (Fig. 4a) . PolFN-~I did not alter the site of envelopment of 2.4N3A virus in nasal epithelium, Table 1 
. Effect of PolFN-~l treatment on P R V infection of various cells 48 h after inoculation
Extent of PRV infection in
Table 2. Effect of PolFN-~l treatment on P R V replication in various porcine cells 48 h after inoculation
Loglo p.f.u./ml supernatant Virus strain Nasal mucosa* Fibroblasts* Kidney cells* NIA-3 7.4/6-0 7-0/1.2 7-3/6-3 2.4N3A
7.5/6.4 6.9/2.0 7-6/6.0 Bartha 7.0/6.6 6.5/1-5 6.8/5.0 * Untreated cultures/cultures treated with 103 U PolFN-ctl.
kidney cells and fibroblasts, although fewer intracellular and extracellular virions were detected in treated cells than in untreated cells (Fig. 4b) . Avirulent Bartha virus replicated in untreated nasal epithelial cells, but did not infect the stromal fibroblasts of mucosal explants. Bartha virus infection in nasal epithelial ceils was characterized by only a few intranuclear nucleocapsids; nucleocapsids emerged from the nucleus and were enveloped in the cytoplasm by budding through the SER membranes, similar to the envelopment of 2 . 4 N 3 A virus (Fig. 4a) . Fewer intracellular and extracellular virions were detected in treated cells than in untreated cells.
Discussion
Based on the virological and morphometric results obtained after PRV infection of fibroblasts, kidney cells and nasal mucosal explants, we demonstrated that PolFN-0tl protected fibroblasts but not epithelial cells from infection with three different strains of PRV; even the avirulent Bartha virus was able to infect IFN-treated epithelial ceils of the nasal mucosal and kidney.
Nonetheless, PolNF-ctl delayed the replication and release of virus in all cell types. These results indicate a cell-specific response to I F N and they agree with the results of Youngner et al. (1972) , who described a PRV strain that was highly sensitive to I F N in chicken embryo fibroblasts, but was completely unaffected by I F N in rabbit kidney cells.
In IFN-treated epithelial cells, many nucleocapsids were detected in the process of budding through membranes. IFN inhibits the production of viral glycoproteins, thus affecting the membrane-associated steps of viral replication (Chatterjee et al., 1985) . Alternatively, IFN may change the fluidity of membranes and thereby disrupt viral morphogenesis (Chatterjee et al., 1982; Pfeffer et al., 1981 ; Wang et al., 1981) .
In earlier studies, we observed that the virulent NIA-3 virus was enveloped at the NM, in contrast to 2.4N3A virus and Bartha virus which were mainly enveloped in the cytoplasm by budding through the SER membranes (J. M. A. Pol, F. Wagenaar & A. Gielkens, unpublished results). After I F N treatment, the site of NIA-3 virus envelopment was partially changed from the N M to the SER membranes and the spread of NIA-3 virus infection was decreased.
Because PolFN-~tl protected fibroblasts so effectively against virus infection, fibroblasts may be the best cells in which to test the sensitivity of PRV to IFN. Nasal mucosal explants are useful because they contain both epithelial cells and fibroblasts and nasal mucosa is also the target tissue in naturally occurring PRV infections in pigs. Because mucosal fibroblasts are well protected by, IFN and because they surround blood vessels, nerve cells and lymphatics (structures by which virus disseminates through the body), infection of fibroblasts may be associated more with virulence than with infection of epithelium cells. IFN is produced by cells within hours of infection (Baron et al., 1982) . If host cell macromolecular synthesis is quickly shut off by the infecting virus, the ceils produce little IFN and the surrounding ceils remain sensitive to the virus.
The virulent NIA-3 virus may cause early shutdown of host cell macromolecular synthesis in infected nasal epithelial cells, thereby preventing the induction of IFN, which might explain the rapid invasion of the stroma by the virus. In untreated nasal mucosa, the replication and release of mildly virulent 2.4N3A virus and, to a greater extent, of avirulent Bartha virus, was delayed compared to that of the virulent NIA-3 virus (Pol et al., 1989) . This delay may permit IFN, which is produced locally by infected epithelial cells, to protect the underlying fibroblasts. The effect of IFN may explain why the two strains are less virulent in vivo. Few stromal fibroblasts of IFN-treated mucosal explants were infected by NIA-3 virus, probably because replication and release of virus was delayed, thus preventing the infection from further invading the stroma.
Epithelial cells produce IFN-fl after infection, but macrophages produce IFN-~ after infection. Many tissue macrophages are normally located in the nasal mucosa and we have demonstrated that IFN-~ effectively protects fibroblasts against PRV infection. In future experiments, we shall investigate the effect of IFN-fl on PRV infections of nasal mucosa.
